Skip to main content

Kiromic BioPharma completes expansion of manufacturing lab to support clinical trials

The 34,000-square-foot facility will allow Kiromic BioPharma to begin a cell therapy clinical trial for a product candidate by the end of the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.